Skip to main content
. 2021 Sep 7;12(1):5932–5949. doi: 10.1080/21655979.2021.1972078

Figure 4.

Figure 4.

Subgroup survival analysis of OS for LUAD patients. (a) Age ≤ 65; (b) Age > 65; (c) Female; (d) Male; (e) Stage I–II; (f) Stage III–IV; (g) With radiotherapy history; (h) Without radiotherapy history